Terns ditches obesity pill and pivots to cancer after mid-stage letdownnews2025-10-22T15:04:19+00:00October 22nd, 2025|Endpoints News|
Top drugmakers’ jets have descended on DC more than 120 times this yearnews2025-10-22T14:45:41+00:00October 22nd, 2025|Endpoints News|
Starna Therapeutics raises $44M to advance in vivo CAR-T programs after early clinical datanews2025-10-22T14:19:51+00:00October 22nd, 2025|Endpoints News|
Japan’s Fast Track Initiative announces new $130M venture fundnews2025-10-22T14:00:10+00:00October 22nd, 2025|Endpoints News|
Summit raises $500M, with more than half coming from its C-suitenews2025-10-22T13:35:53+00:00October 22nd, 2025|Endpoints News|
Sanofi reveals Phase 2 rare disease win from Inhibrx buyoutnews2025-10-22T13:27:00+00:00October 22nd, 2025|Endpoints News|
Alector’s GSK-partnered dementia drug flunks Phase 3, plots to halve workforcenews2025-10-22T12:58:17+00:00October 22nd, 2025|Endpoints News|
Sanofi backs immunology startup, which raises $183M Series C for lead drug’s pivotal trialnews2025-10-22T11:00:41+00:00October 22nd, 2025|Endpoints News|
Flagship debuts AI biotech startup Expedition with $50Mnews2025-10-22T10:30:19+00:00October 22nd, 2025|Endpoints News|
Ipsen to buy ImCheck for €350M to get ‘superfamily’ of immunotherapiesnews2025-10-22T10:28:46+00:00October 22nd, 2025|Endpoints News|
